Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
OnKure Therapeutics is a biopharmaceutical company specializing in precision cancer medicines. Its core focus is developing highly selective small molecule inhibitors targeting mutated oncogenes, particularly PI3Kα mutations in breast and other cancers. The company’s pipeline includes mutation-specific therapies designed to improve efficacy and safety, with a strategic emphasis on targeted, mutation-driven treatments for underserved patient populations in oncology.
This description was generated via AI from an annual report. Updated about 1 year ago.